Brokerages Set Healthpeak Properties, Inc. (NYSE:DOC) PT at $20.18

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have received an average recommendation of “Moderate Buy” from the twelve research firms that are covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $20.1818.

A number of equities research analysts have issued reports on the company. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research report on Monday, September 15th. Robert W. Baird cut their target price on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. Cantor Fitzgerald assumed coverage on Healthpeak Properties in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target for the company. Wells Fargo & Company lifted their price objective on shares of Healthpeak Properties from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 25th. Finally, Jefferies Financial Group cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating and cut their price objective for the company from $21.00 to $17.00 in a research report on Monday, December 15th.

Institutional Trading of Healthpeak Properties

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC boosted its position in shares of Healthpeak Properties by 2.4% during the second quarter. Fifth Third Wealth Advisors LLC now owns 22,811 shares of the real estate investment trust’s stock valued at $399,000 after buying an additional 543 shares during the period. CoreCap Advisors LLC raised its holdings in shares of Healthpeak Properties by 22.4% in the third quarter. CoreCap Advisors LLC now owns 3,352 shares of the real estate investment trust’s stock worth $64,000 after buying an additional 613 shares during the period. Fiduciary Trust Co lifted its stake in shares of Healthpeak Properties by 4.9% during the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after acquiring an additional 644 shares during the last quarter. Arjuna Capital lifted its stake in shares of Healthpeak Properties by 4.8% during the 3rd quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust’s stock worth $283,000 after acquiring an additional 679 shares during the last quarter. Finally, LRI Investments LLC boosted its holdings in Healthpeak Properties by 18.4% during the 2nd quarter. LRI Investments LLC now owns 4,481 shares of the real estate investment trust’s stock valued at $78,000 after acquiring an additional 697 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Trading Up 0.7%

DOC stock opened at $16.20 on Monday. The firm has a fifty day moving average price of $17.17 and a 200 day moving average price of $17.73. Healthpeak Properties has a fifty-two week low of $15.71 and a fifty-two week high of $21.28. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.22 and a current ratio of 1.22. The firm has a market cap of $11.25 billion, a PE ratio of -323.84, a price-to-earnings-growth ratio of 4.10 and a beta of 1.12.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. The business had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The business’s revenue was up .8% on a year-over-year basis. During the same period last year, the company posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Sell-side analysts anticipate that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.